Administration of Anti-TNF Antibody Improves Left Ventricular Function in Septic Shock Patients
- 1 March 1992
- Vol. 101 (3) , 810-815
- https://doi.org/10.1378/chest.101.3.810
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone AdministrationAmerican Review of Respiratory Disease, 1989
- Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humansCritical Care Medicine, 1989
- Plasma tumor necrosis factor and mortality in critically ill septic patientsCritical Care Medicine, 1989
- Recombinant Human Tumor Necrosis Factor Produces Hemodynamic Changes Characteristic of Sepsis and EndotoxemiaArchives of Surgery, 1989
- Tumor necrosis factor and the acute metabolic response to tissue injury in man.Journal of Clinical Investigation, 1988
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986